TY - JOUR
T1 - Quantitative autoradiography of [3H]piquindone binding sites (dopamine D2 receptors) in rat brain
AU - Nock, Bruce
AU - Sedvall, Göran
AU - McEwen, Bruce S.
N1 - Funding Information:
Dr. G.L. Olson who provided the desmethyl piquindone enantiomers and Dr. E. Ehrin who synthesized tritiated piquindone are gratefully acknowledged. We thank Mr. D.J. Berck and the late Dr. T.C. Rainbow for the software used for densitometry. The present work was supported by NIH Research Grant NS07080 (B.McE) and by NIH National Research Service Award NS06966 (B.N.) and was performed when GOran Sedvall was the first recipient of the Gunnar Nicholson award for scientific exchange between the Rockefeller University and the Karolinska Institute.
PY - 1986/3/4
Y1 - 1986/3/4
N2 - (-)Piquindone is a new antipsychotic pyrroloisoquinoline derivative that binds to dopamine D2 receptors. We used in vitro quantitative autoradiography to determine the distribution of [3H](-)piquindone binding sites in rat forebrain. [3H](-)Piquindone binding to brain slices was sodium dependent, saturable and of high affinity (Kd = 5 nM at 0°C). In autoradiographic experiments, there was a good signal to noise ratio for [3H](-)piquindone binding with nonspecific binding representing only about 20% of total binding in caudate putamen. The D2 antagonists (-)sulpiride and raclopride were much more potent inhibitors of [3H](-)piquindone binding than the D1 antagonist SCH 23390. Dopamine inhibited binding with a potency similar to that previously found with standard membrane binding procedures. Autoradiography indicated that binding sites for [3H](-)piquindone are localized to olfactory tubercle, accumbens nucleus, caudate putamen, cell bridges between caudate putamen and olfactory tubercle, and substantia nigra. Binding in these areas is stereoselective since we found no specific binding with [3H](+)piquindone, the biologically inactive enantiomer. Within caudate putamen, there was a lateral to medial gradient in the optical density of [3H](-)piquindone autoradiograms which might, in part, be attributable to white matter density rather than to D2 receptors.
AB - (-)Piquindone is a new antipsychotic pyrroloisoquinoline derivative that binds to dopamine D2 receptors. We used in vitro quantitative autoradiography to determine the distribution of [3H](-)piquindone binding sites in rat forebrain. [3H](-)Piquindone binding to brain slices was sodium dependent, saturable and of high affinity (Kd = 5 nM at 0°C). In autoradiographic experiments, there was a good signal to noise ratio for [3H](-)piquindone binding with nonspecific binding representing only about 20% of total binding in caudate putamen. The D2 antagonists (-)sulpiride and raclopride were much more potent inhibitors of [3H](-)piquindone binding than the D1 antagonist SCH 23390. Dopamine inhibited binding with a potency similar to that previously found with standard membrane binding procedures. Autoradiography indicated that binding sites for [3H](-)piquindone are localized to olfactory tubercle, accumbens nucleus, caudate putamen, cell bridges between caudate putamen and olfactory tubercle, and substantia nigra. Binding in these areas is stereoselective since we found no specific binding with [3H](+)piquindone, the biologically inactive enantiomer. Within caudate putamen, there was a lateral to medial gradient in the optical density of [3H](-)piquindone autoradiograms which might, in part, be attributable to white matter density rather than to D2 receptors.
KW - Antipsychotic drugs
KW - Dopamine D receptors
KW - In vitro autoradiography
KW - Neuroleptic drugs
KW - Piquindone
KW - Ro 22-1319
UR - http://www.scopus.com/inward/record.url?scp=0022558427&partnerID=8YFLogxK
U2 - 10.1016/0014-2999(86)90259-1
DO - 10.1016/0014-2999(86)90259-1
M3 - Article
C2 - 3699100
AN - SCOPUS:0022558427
SN - 0014-2999
VL - 121
SP - 387
EP - 393
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 3
ER -